← All indications
Antithrombin III Deficiency
An absence or reduced level of Antithrombin III leading to an increased risk for thrombosis.
Drugs by status
Approved for this indication (1)
Phase 4 trials (1)
Phase 1 trials (1)
Organizations
Organization Involved with Phase 4 Indications (5)
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (2)
Organization Involved with Phase 1 Indications (2)